In the United States decided to profit from cancer patients and raised the price of the drug 15 times

a Group of U.S. senators initiated the investigation aimed to establish why the price has long used anticancer drug lomustine has risen in the U.S. since 2013, more than 1,400 percent. This writes the newspaper The Hill.

the Congressmen sent the head of the company Tri-Source Pharma Robert Dikici a letter demanding to explain what caused the price surge and the profit which as a result gets his firm. They pointed out that before 2013, Tri-Pharma Source acquired from another company the rights to release lomustine, one capsule of the drug worth $ 50. Currently it sells for $ 768.

Lomustine is used since 1976 in the treatment of diseases such as primary and metastatic brain tumors, lymphogranulomatosis (Hodgkin disease), cancer of the stomach and intestines.

the Senators reminded the head of the pharmaceutical company destiny Martin Shkreli. It is 55 times raised the price of the drug pyrimethamine, used for treatment of toxoplasmosis in patients with AIDS. After acquiring the rights to release the drug, its price has risen from 13.5 to $ 750. March 9, the court acknowledged Shkreli guilty of fraud with securities and was sent to jail for seven years.